Literature DB >> 27872652

Corrigendum to "Effects of an Aqueous Extract of Dangguijagyagsan on Serum Lipid Levels and Blood Flow Improvement in Ovariectomized Rats".

In Sil Park1, Hye Won Lee1, Jin Ah Ryuk1, Byoung Seob Ko1.   

Abstract

[This corrects the article DOI: 10.1155/2014/497836.].

Entities:  

Year:  2016        PMID: 27872652      PMCID: PMC5107236          DOI: 10.1155/2016/7249813

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


In the article titled “Effects of an Aqueous Extract of Dangguijagyagsan on Serum Lipid Levels and Blood Flow Improvement in Ovariectomized Rats” [1] there were errors, which should be corrected as follows. In Table 2, the body weight gain and sample size are incorrect. The corrected table is presented here. In Figure 2, the sample size was not n = 5–7 but n = 4 in each group. The corrected sample size is presented here. In the Abstract, “These effects were reduced by ASA and DJS treatment” should read “Other than body weight gain, these effects were reduced by ASA and DJS treatment.” In the Results, “In the OVX-control group, treatment with saline demonstrated a significant increase in body weight gain compared to the Sham-control group (5.7 ± 2.4 g/day versus 3.7 ± 2.7 g/day, P < 0.001). The body weight gain was slightly decreased in the OVX-ASA (5.4 ± 2.4 g/day) and OVX-DJS groups (5.1 ± 2.2 g/day) compared with OVX-control group, although not significantly compared with the Sham-control group (P > 0.05)” should read “All OVX groups showed a similar body weight gain (OVX-control 3.82 ± 0.65 g/day; OVX-ASA 3.84 ± 0.60 g/day; OVX-DJS 3.79 ± 0.75 g/day) compared to the Sham-control group (2.94 ± 0.59 g/day).” In the Discussion, “In the present study, body weight gain was significantly increased in OVX-control group compared to Sham-control group for five-week treatment and there were no significant weight gain differences in OVX-ASA and OVX-DJS groups compared to OVX-control group. However, food intake in OVX-ASA and OVX-DJS group had much consumption compared to OVX-control group and these results suggest that administration of DJS could have beneficial effect on obesity in menopause” should read “In the present study, body weight gain was significantly increased in all OVX groups compared to Sham-control group for five-week treatment. However, food intake in OVX-ASA and OVX-DJS group had increased consumption compared to OVX-control group.”
Table 2

Effect of DJS administration on body weight gain and food intake of OVX rats.

GroupFinal body weight (g)Body weight gain (g/day)Food intake (g/day)
Sham306.83 ± 19.04a 2.94 ± 0.59a 17.02 ± 2.12a
OVX-control341.15 ± 21.85b 3.82 ± 0.65b 17.72 ± 2.84a
OVX-ASA345.91 ± 19.93b 3.84 ± 0.60b 19.14 ± 3.71b
OVX-DJS346.54 ± 23.62b 3.79 ± 0.75b 19.39 ± 3.22b

Results are mean ± SD (n = 10–12). Means of letters recorded as a and b within a column indicated the same level of body weight and food intake within the values determined by one-way ANOVA. OVX: ovariectomized; ASA: aspirin; DJS: Dangguijagyagsan.

  1 in total

1.  Effects of an aqueous extract of dangguijagyagsan on serum lipid levels and blood flow improvement in ovariectomized rats.

Authors:  In Sil Park; Hye Won Lee; Jin Ah Ryuk; Byoung Seob Ko
Journal:  Evid Based Complement Alternat Med       Date:  2014-09-07       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.